Table 4.
Increase of erythrocyte plasmalogen in PD after administration of scallop-derived ether phospholipids.
| Variable (%) | Before | After 12 weeks | p value∗ | After 24 weeks | p value∗ |
|---|---|---|---|---|---|
| plsPE | 7.67 (0.78) | 8.43 (1.2) | 0.03 | 8.64 (0.97) | 0.01 |
| PE | 9.71 (0.81) | 10.12 (0.77) | 0.32 | 10.81 (0.95) | 0.03 |
| PC | 23.25 (1.74) | 23.54 (3.29) | 0.83 | 25.41 (1.74) | 0.006 |
| SM | 49.99 (3.1) | 47.87 (5.41) | 0.39 | 44.83 (2.65) | 0.004 |
| PS | 9.34(1.14) | 10.05 (1.08) | 0.13 | 10.33 (0.75) | 0.01 |
Values are mean (SD) unless otherwise specified. plsPE: ethanolamine plasmalogen; PE: diacyl ethanolamine glycerophospholipid; PC: diacyl choline glycerophospholipid; PS: diacyl serine glycerophospholipid; SM: sphingomyelin. ∗Differences from immediate before trial.